These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 9018803)

  • 21. [Detection of weak D antigen by flow cytometry].
    Wu XY; Xu HX; Xiong W; Shao CP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Apr; 21(2):474-7. PubMed ID: 23628057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular basis of the rare gene complex, DIVa(C)-, which encodes four low-prevalence antigens in the Rh blood group system.
    Hipsky CH; Hue-Roye K; Lomas-Francis C; Huang CH; Reid ME
    Vox Sang; 2012 Feb; 102(2):167-70. PubMed ID: 21729099
    [TBL] [Abstract][Full Text] [Related]  

  • 23. D category IV: a group of clinically relevant and phylogenetically diverse partial D.
    von Zabern I; Wagner FF; Moulds JM; Moulds JJ; Flegel WA
    Transfusion; 2013 Nov; 53(11 Suppl 2):2960-73. PubMed ID: 23461862
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serologic and molecular investigations of DAR1 (weak D Type 4.2), DAR1.2, DAR1.3, DAR2 (DARE), and DARA.
    Lejon Crottet S; Haer-Wigman L; Gowland P; Fontana S; Niederhauser C; Hustinx H
    Transfusion; 2013 Nov; 53(11 Suppl 2):3000-8. PubMed ID: 23902153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel weak D types 31 and 32: adsorption-elution-supported D antigen analysis and comparison to prevalent weak D types.
    Körmöczi GF; Förstemann E; Gabriel C; Mayr WR; Schönitzer D; Gassner C
    Transfusion; 2005 Oct; 45(10):1574-80. PubMed ID: 16181207
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of the hybrid RHD gene leading to the partial D category IIIc phenotype.
    Beckers EA; Faas BH; Ligthart P; Simsek S; Overbeeke MA; von dem Borne AE; van Rhenen DJ; van der Schoot CE
    Transfusion; 1996 Jun; 36(6):567-74. PubMed ID: 8669091
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IgG anti-D MAbs in tests by flow cytometry.
    Roubinet F; Blancher A
    Transfus Clin Biol; 1996; 3(6):419-23. PubMed ID: 9018801
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Partial deletion of the D antigen in a family group. Determination of its antigenic density by flow cytometry].
    Hernández T; León G; Sánchez P
    Sangre (Barc); 1994 Apr; 39(2):139-43. PubMed ID: 7520193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rh flow cytometry: An updated methodology for D antigen density applied to weak D types 164 and 165.
    Hutchison CJ; Srivastava K; Polin H; Bueno MU; Flegel WA
    Transfusion; 2023 Nov; 63(11):2141-2151. PubMed ID: 37792462
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Varied distribution of RhD epitopes in the Indian population.
    Kulkarni SS; Gupte SC; Vasantha K; Mohanty D; Ghosh K
    Natl Med J India; 2007; 20(4):169-71. PubMed ID: 18085120
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The application of flow cytometry in analysis of erythrocyte antigen determinants].
    Amemiya Y; Hashimoto Y; Obata T; Nakagi Y; Miura Y
    Rinsho Ketsueki; 1990 Jun; 31(6):702-12. PubMed ID: 1699003
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A RhD negative patient failed to produce detectable anti-D after transfusion of 35 units of RhD positive red blood cells].
    Lee WM; Kim JH; Ha JS; Ryoo NH; Jeon DS; Kim JR; Cho D
    Korean J Lab Med; 2007 Oct; 27(5):369-72. PubMed ID: 18094603
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isolation, characterization, and family study of DTI, a novel partial D phenotype affecting the fourth external loop of D polypeptides.
    Omi T; Takahashi J; Seno T; Tanaka M; Hirayama F; Matsuo M; Ueda N; Obara K; Okuda H; Iwamoto S; Tani Y; Kajii E
    Transfusion; 2002 Apr; 42(4):481-9. PubMed ID: 12076297
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diverse and novel RHD variants in Australian blood donors with a weak D phenotype: implication for transfusion management.
    McGowan EC; Lopez GH; Knauth CM; Liew YW; Condon JA; Ramadi L; Parsons K; Turner EM; Flower RL; Hyland CA
    Vox Sang; 2017 Apr; 112(3):279-287. PubMed ID: 28220510
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epitope mapping of four monoclonal antibodies specific for the human RhD antigen.
    Nickerson L; Wiersma EJ
    Immunol Lett; 2002 Jan; 80(1):33-9. PubMed ID: 11716963
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Flow cytometric analysis of erythrocytic D antigen density profile.
    van Bockstaele DR; Berneman ZN; Muylle L; Cole-Dergent J; Peetermans ME
    Vox Sang; 1986; 51(1):40-6. PubMed ID: 3090784
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Secondary anti-D immunization by Del red blood cells.
    Yasuda H; Ohto H; Sakuma S; Ishikawa Y
    Transfusion; 2005 Oct; 45(10):1581-4. PubMed ID: 16181208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of Rh phenotype on the antigen density of C, c, and D: flow cytometric study using a frozen standard red cell.
    Wagner FF
    Transfusion; 1994 Aug; 34(8):671-6. PubMed ID: 8073482
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Flow cytometric analysis of the Rh1 (Rho, D) antigen activity on red cells: various Rh blood group phenotypes including Du variants.
    Ota M; Hasekura H; Fukushima H; Yonemura I
    Nihon Hoigaku Zasshi; 1989 Apr; 43(2):122-7. PubMed ID: 2509769
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Preliminary study on conversion of RhD positive red blood cells to RhD negative by modification with methoxy polyethylene glycol].
    Li LL; Wang JX; Tan YX; Zhang YP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Dec; 11(6):654-8. PubMed ID: 14706154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.